Medpace experts talk about the opportunities for the microbiome and clinical development
Discoveries over the past decade have revealed the power of microbes to prevent, diagnose and treat disease. As a result, clinical research and development in new therapies and diagnostics is rapidly advancing our understanding of how dysbiosis of the microbiome can result in disease and how prevention or reversal of microbial imbalances can be used in treatment.
Medpace recently collaborated with Diversigen to discuss the topic of the microbiome in clinical trials, touching on both the opportunities and the challenges. Fill out the form to get access to the following resources:
- Webinar: Opportunities and Challenges in Microbiome-based Clinical Research
- Whitepaper: The Microbiome in Clinical Trials: Opportunities and Challenges
